Assignee
UPPTHERA
KR·5 granted patents·5 pending applications·3 citations·filing 2021–2023
Top patents by PatentIndex Score
10 records- 0187US11066391B1Atorvastatin derived HMG-CoA reductase degradation inducing compoundUPPTHERA·Filed 2021·Granted Jul 20, 2021·2 cites·3 claims
- 0280US11833208B2PLK1 selective degradation inducing compoundUPPTHERA·Filed 2021·Granted Dec 5, 2023·1 cites·8 claims
- 0371US2023372498A1Plk1 selective degradation inducing compoundUPPTHERA·Filed 2023·Application pending·0 cites
- 0465US12403198B2Benzimidazole thiophene derivative compounds inducing selective degradation of PLK1UPPTHERA·Filed 2021·Granted Sep 2, 2025·0 cites·7 claims
- 0560US2023027819A1Cell-penetrating peptide dimers, method for preparing the same, and cargo delivery system using the sameUPPTHERA·Filed 2022·Application pending·0 cites
- 0657US11358992B2Cell-penetrating cereblon recombinant fusion protein and use thereofUPPTHERA·Filed 2021·Granted Jun 14, 2022·0 cites·2 claims
- 0755US2024000951A1Gpx4 protein degradation-inducing compoundUPPTHERA·Filed 2021·Application pending·0 cites
- 0854US2025073218A1Nlrp3 protein degradation inducing compoundUPPTHERA·Filed 2021·Application pending·0 cites
- 0954US2021300977A1Cell-penetrating peptide dimers, method for preparing the same, and cargo delivery system using the sameUPPTHERA·Filed 2021·Application pending·0 cites
- 1050US12479840B2HMG-CoA reductase degradation inducing compoundUPPTHERA·Filed 2021·Granted Nov 25, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when UPPTHERA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →